Product Information
CELECOXIB 400 MG CAPSULE is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.2480 per EA under NDC 33342015809. Its NADAC has been published 491 times since May 10, 2017.
FDA first approved this application on Mar 16, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342015809
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CELECOXIBApproval Type
Generic (ANDA)
FDA Application
ANDA204590FDA Approved
3/16/2016
TE Code
AB
On Market Since
3/16/2016
Pharmacological Classes
Price Statistics
The NADAC for CELECOXIB 400 MG CAPSULE has been published 491 times since May 10, 2017, and over the history we have for it it has declined 87.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2480 per EA |
|---|---|
| All-time high | $1.9552 (Jun 14, 2017) |
| All-time low | $0.2055 (Jul 22, 2026) |
| 52-week high | $0.3409 |
| 52-week low | $0.2055 |
| Median price | $0.6319 |
| Average price | $0.6758 |
| Largest weekly change | +54.7% (Jun 22, 2022) |
| Weeks tracked | 491 |
| Tracking since | May 10, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
celecoxib market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CELECOXIB 400 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CELECOXIB 400 MG CAPSULE, manufactured by Macleods Pharmaceuticals Limited, is $0.2480 per EA (NDC 33342015809), effective Sep 30, 2026.
How has the price of CELECOXIB 400 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CELECOXIB 400 MG CAPSULE has declined 87.3%. It has been tracked across 491 weekly CMS publications since May 10, 2017.
What are the highest and lowest recorded NADAC prices for CELECOXIB 400 MG CAPSULE?
Since May 10, 2017, the NADAC for CELECOXIB 400 MG CAPSULE has ranged from a low of $0.2055 (Jul 22, 2026) to a high of $1.9552 (Jun 14, 2017), with a median of $0.6319 per EA.
Are there cheaper alternatives to CELECOXIB 400 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CELECOXIB 400 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures CELECOXIB 400 MG CAPSULE?
CELECOXIB 400 MG CAPSULE (NDC 33342015809) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.